Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1976 Jan;39(1):23–33. doi: 10.1136/jnnp.39.1.23

Genetic associations between myasthenia gravis and the HL-A system.

R Pirskanen
PMCID: PMC492209  PMID: 1255208

Abstract

HL-A antigens were determined in 159 myasthenic patients, 112 of whom were females and 47 males. Fifty-seven patients were thymectomized. The relationship between 23 different HL-A antigens and myasthenia gravis (MG) with reference to sex, age at onset, clinical course of MG, thymus histology, and auxiliary diseases of the patients, as well as the significance of these antigens to 245 relatives of myasthenics, were analysed. The frequencies of HL-A1 and HL-A8 were highly significantly higher in myasthenic patients than in normal Finnish controls. The increase of HL-A1 is secondary and due to a strong linkage disequilibrium between HL-A8 and HL-A1. HL-A8 appeared most often in females with onset of MG before the age of 35 years, and inpatients with thymus hyperplasia. No significant HL-A deviations were found in males or in females with later onset of disease. In seven thymoma patients the occurrence of W10 antigen was almost significantly increased.

Full text

PDF
30

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alpert L. I., Rule A., Norio M., Kott E., Kornfeld P., Osserman K. E. Studies in myasthenia gravis: cellular hypersensitivity to skeletal muscle. Am J Clin Pathol. 1972 Dec;58(6):647–653. doi: 10.1093/ajcp/58.6.647. [DOI] [PubMed] [Google Scholar]
  2. Armstrong R. M., Nowak R. M., Falk R. E. Thymic lymphocyte function in myasthenia gravis. Neurology. 1973 Oct;23(10):1078–1083. doi: 10.1212/wnl.23.10.1078. [DOI] [PubMed] [Google Scholar]
  3. Behan P. O., Simpson J. A., Dick H. Letter: Immune response genes in myasthenia gravis. Lancet. 1973 Nov 3;302(7836):1033–1033. doi: 10.1016/s0140-6736(73)91130-6. [DOI] [PubMed] [Google Scholar]
  4. Ceppellini R., van Rood J. J. The HL-A system. I. Genetics and molecular biology. Semin Hematol. 1974 Jul;11(3):233–251. [PubMed] [Google Scholar]
  5. Feltkamp T. E., van den Berg-Loonen P. M., Nijenhuis L. E., Engelfriet C. P., van Rossum A. L., van Loghem J. J., Oosterhuis H. J. Myasthenia gravis, autoantibodies, and HL-A antigens. Br Med J. 1974 Jan 26;1(5899):131–133. doi: 10.1136/bmj.1.5899.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fritze D., Herrman C., Jr, Naeim F., Smith G. S., Walford R. L. HL-A antigens in myasthenia gravis. Lancet. 1974 Feb 16;1(7851):240–242. doi: 10.1016/s0140-6736(74)92548-3. [DOI] [PubMed] [Google Scholar]
  7. Gebhard R. L., Katz S. I., Marks J., Shuster S., Trapani R. J. HL-A antigen type and small-intestinal disease in dermatitis herpetiformis. Lancet. 1973 Oct 6;2(7832):760–762. doi: 10.1016/s0140-6736(73)91039-8. [DOI] [PubMed] [Google Scholar]
  8. Grumet F. C., Coukell A., Bodmer J. G., Bodmer W. F., McDevitt H. O. Histocompatibility (HL-A) antigens associated with systemic lupus erythematosus. A possible genetic predisposition to disease. N Engl J Med. 1971 Jul 22;285(4):193–196. doi: 10.1056/NEJM197107222850403. [DOI] [PubMed] [Google Scholar]
  9. Kott E., Genkins G., Rule A. H. Leukocyte response to muscle antigens in myasthenia gravis. Relationship to clinical severity and presence of circulating antibodies. Neurology. 1973 Apr;23(4):374–380. doi: 10.1212/wnl.23.4.374. [DOI] [PubMed] [Google Scholar]
  10. Mackay I. R., Morris P. J. Association of autoimmune active chronic hepatitis with HL-A1,8. Lancet. 1972 Oct 14;2(7781):793–795. doi: 10.1016/s0140-6736(72)92149-6. [DOI] [PubMed] [Google Scholar]
  11. McDevitt H. O., Bodmer W. F. HL-A, immune-response genes, and disease. Lancet. 1974 Jun 22;1(7869):1269–1275. doi: 10.1016/s0140-6736(74)90021-x. [DOI] [PubMed] [Google Scholar]
  12. NASTUK W. L., STRAUSS A. J., OSSERMAN K. E. Search for a neuromuscular blocking agent in the blood of patients with myasthenia gravis. Am J Med. 1959 Mar;26(3):394–409. doi: 10.1016/0002-9343(59)90248-7. [DOI] [PubMed] [Google Scholar]
  13. Namba T., Arimori S., Grob D. Effect on mice of intravenous administration of lymphocytes from normal subjects and from patients with myasthenia gravis. Neurology. 1969 May;19(5):461–468. doi: 10.1212/wnl.19.5.461. [DOI] [PubMed] [Google Scholar]
  14. Namba T., Arimori S., Grob D. Lymphocytes of patients with myasthenia gravis. Local effects in rats following intramuscular administration. Arch Neurol. 1969 Sep;21(3):285–295. doi: 10.1001/archneur.1969.00480150075010. [DOI] [PubMed] [Google Scholar]
  15. Namba T., Brunner N. G., Brown S. B., Muguruma M., Grob D. Familial myasthenia gravis. Report of 27 patients in 12 families and review of 164 patients in 73 families. Arch Neurol. 1971 Jul;25(1):49–60. doi: 10.1001/archneur.1971.00490010059009. [DOI] [PubMed] [Google Scholar]
  16. Nerup J., Platz P., Andersen O. O., Christy M., Lyngsoe J., Poulsen J. E., Ryder L. P., Nielsen L. S., Thomsen M., Svejgaard A. HL-A antigens and diabetes mellitus. Lancet. 1974 Oct 12;2(7885):864–866. doi: 10.1016/s0140-6736(74)91201-x. [DOI] [PubMed] [Google Scholar]
  17. OOSTERHUIS H. J. STUDIES IN MYASTHENIA GRAVIS. 1. A CLINICAL STUDY OF 180 PATIENTS. J Neurol Sci. 1964 Nov-Dec;1(6):512–546. doi: 10.1016/0022-510x(64)90171-6. [DOI] [PubMed] [Google Scholar]
  18. Oosterhuis H. J., de Haas W. H. Rheumatic diseases in patients with myasthenia gravis. An epidemiological and clinical investigation. Acta Neurol Scand. 1968;44(2):219–227. doi: 10.1111/j.1600-0404.1968.tb05568.x. [DOI] [PubMed] [Google Scholar]
  19. Pirskanen R., Tiilikainen A., Hokkanen E. Histocompatibility (HL-A) antigens associated with myasthenia gravis. A preliminary report. Ann Clin Res. 1972 Oct;4(5):304–306. [PubMed] [Google Scholar]
  20. Platz P., Ryder L., Nielsen L. S., Svejgaard A., Thomsen M., Nerup J., Christy M. Letter: HL-A and idiopathic Addison's disease. Lancet. 1974 Aug 3;2(7875):289–289. doi: 10.1016/s0140-6736(74)91450-0. [DOI] [PubMed] [Google Scholar]
  21. Stokes P. L., Asquith P., Holmes G. K., Mackintosh P., Cooke W. T. Histocompatibility antigens associated with adult coeliac disease. Lancet. 1972 Jul 22;2(7769):162–164. doi: 10.1016/s0140-6736(72)91330-x. [DOI] [PubMed] [Google Scholar]
  22. Säfwenberg J., Lindblom J. B., Osterman P. O. HL-A frequencies in patients with myasthenia gravis. Tissue Antigens. 1973;3(6):465–469. doi: 10.1111/j.1399-0039.1973.tb00516.x. [DOI] [PubMed] [Google Scholar]
  23. Thorsby E., Engeset A., Lie S. O. HL-A antigens and susceptibility to diseases. A study of patients with acute lymphoblastic leukaemia, Hodgkin's disease, and childhood asthma. Tissue Antigens. 1971;1(3):147–152. doi: 10.1111/j.1399-0039.1971.tb00091.x. [DOI] [PubMed] [Google Scholar]
  24. Whittingham S., Mackay I. R., Kiss Z. S. An interplay of genetic and environmental factors in familial hepatitis and myasthenia gravis. Gut. 1970 Oct;11(10):811–816. doi: 10.1136/gut.11.10.811. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES